Robert Kantrowitz

Since joining Kirkland, Robert has been involved in the following matters:

• KKR & Co. L.P. in its acquisition of a majority interest in Therapy Brands, a leading practice management and electronic health record software platform.
• Nordic Capital in its acquisition of United Veterinary Care.
• Bain Capital in its management of HST Pathways.
• MRO Corp. in its acquisition of Cobius Healthcare Solutions, a provider of reimbursement and compliance risk management tools for hospitals, healthcare systems and physicians.
• EW Healthcare Partners-backed Cognate BioServices in its sale to Charles River Laboratories.
• The Susan G. Komen Foundation in its implementation of a patient navigator program and related privacy matters.
• Olympus Partners in its acquisitions of ONsite Mammography.
• BC Partners in its acquisition of Women’s Care Enterprises.
• Sphere in its acquisition of Patient Engagement and Revenue Cycle Management Platform, Health iPASS
• Brookfield in its acquisition of Everise
• Starr Investment Holdings, LLC in its sale of ConvenientMD
• MRO, Corp. in its acquisition of Clinical Data Interoperability Company, FIGmd
• Bain Capital in the investment in PartsSource
• Windjammer on the closing of a Continuation Fund transaction of Vital Records, LLC

Prior to joining Kirkland, Robert was involved in the following matters:

• Smith & Nephew in its $660 million acquisition of Osiris Therapeutics, Inc. 
• Venus Concept Ltd. in connection with its merger with Restoration Robotics, Inc.
• A major New York HMO in connection with its sale to one of the largest providers of government-sponsored health insurance in the U.S.

Associate, Health Care/Life Sciences & Intellectual Property Technology/Data, Reed Smith LLP